Smith Alan E - Insider Trading & Ownership

Entity
Company
Location
One Kendall Square, Cambridge, MA
Summary
The estimated value of insider holdings of Smith Alan E is at least $29.3K dollars as of July 26, 2021. Smith Alan E is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $29.3K.
All Insider Reports
All Insider Reports

Ownership of Smith Alan E

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CADL Candel Therapeutics, Inc. Director $29.3K Jul 26, 2021

There are no insider transactions reported by Smith Alan E